My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    1.

    NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection.

    Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G.

    Ann Intern Med. 1991 Apr 15;114(8):678-93. Review.PMID: 1672248 [PubMed - indexed for MEDLINE]Related articles

    2.

    Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.

    Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ.

    N Engl J Med. 1997 Oct 30;337(18):1267-74.PMID: 9345075 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load.

    Sindhu ST, Ahmad R, Morisset R, Ahmad A, Menezes J.

    J Virol. 2003 Feb;77(3):1848-55.PMID: 12525619 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Immunological features of human immunodeficiency virus disease.

    Seligmann M.

    Baillieres Clin Haematol. 1990 Jan;3(1):37-63. Review.PMID: 2138920 [PubMed - indexed for MEDLINE]Related articles

    5.

    Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication.

    Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP.

    Blood. 1997 Feb 15;89(4):1357-63.PMID: 9028959 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Immunopathogenic mechanisms of HIV infection.

    Rosenberg ZF, Fauci AS.

    Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S149-56. Review.PMID: 2562941 [PubMed - indexed for MEDLINE]Related articles

    7.

    Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.

    Zheng NN, McElrath MJ, Sow PS, Hawes SE, Diallo-Agne H, Stern JE, Li F, Mesher AL, Robinson AD, Gottlieb GS, Huang Y, Kiviat NB.

    J Virol. 2007 Sep;81(17):9061-71. Epub 2007 Jun 20.PMID: 17582003 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.

    Carmichael A, Jin X, Sissons P, Borysiewicz L.

    J Exp Med. 1993 Feb 1;177(2):249-56.PMID: 8093890 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The value of preserving HIV-specific immune responses.

    Kaufmann DE, Rosenberg ES.

    J HIV Ther. 2003 Feb;8(1):19-25. Review.PMID: 12840711 [PubMed - indexed for MEDLINE]Related articles

    10.

    Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group.

    Livingstone WJ, Moore M, Innes D, Bell JE, Simmonds P.

    Lancet. 1996 Sep 7;348(9028):649-54.PMID: 8782755 [PubMed - indexed for MEDLINE]Related articles

    11.

    Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity.

    Ostrowski MA, Yu Q, Yue FY, Liu J, Jones B, Gu XX, Loutfy M, Kovacs CM, Halpenny R.

    Immunol Res. 2006;35(1-2):89-102. Review.PMID: 17003512 [PubMed - indexed for MEDLINE]Related articles

    12.

    Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.

    Betts MR, Gray CM, Cox JH, Ferrari G.

    Expert Rev Vaccines. 2006 Aug;5(4):505-16. Review.PMID: 16989631 [PubMed - indexed for MEDLINE]Related articles

    13.

    AIDS: immunologic abnormalities following human immunodeficiency virus infection.

    Batra P.

    J Thorac Imaging. 1991 Sep;6(4):1-5. Review.PMID: 1942190 [PubMed - indexed for MEDLINE]Related articles

    14.

    Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.

    Nehete PN, Chitta S, Hossain MM, Hill L, Bernacky BJ, Baze W, Arlinghaus RB, Sastry KJ.

    Vaccine. 2001 Dec 12;20(5-6):813-25.PMID: 11738745 [PubMed - indexed for MEDLINE]Related articles

    15.

    Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.

    Wagner R, Deml L, Schirmbeck R, Reimann J, Wolf H.

    Behring Inst Mitt. 1994 Dec;(95):23-34. Review.PMID: 7755506 [PubMed - indexed for MEDLINE]Related articles

    16.

    CD8 lymphocytes in HIV infection: helpful and harmful.

    Famularo G, Moretti S, Marcellini S, Nucera E, De Simone C.

    J Clin Lab Immunol. 1997;49(1):15-32. Review.PMID: 9819670 [PubMed - indexed for MEDLINE]Related articles

    17.

    Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.

    Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, Hoelzer D, Rossol R.

    AIDS. 1997 Jul 15;11(9):1111-8.PMID: 9233457 [PubMed - indexed for MEDLINE]Related articles

    18.

    The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes--a review, hypothesis and implications for treatment.

    Becker Y.

    Virus Genes. 2007 Apr;34(2):93-109. Review.PMID: 17151939 [PubMed - indexed for MEDLINE]Related articles

    19.

    Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals.

    Engelmayer J, Larsson M, Lee A, Lee M, Cox WI, Steinman RM, Bhardwaj N.

    J Virol. 2001 Mar;75(5):2142-53.PMID: 11160718 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?

    Bucy RP, Kilby JM.

    AIDS. 2001 Feb;15 Suppl 2:S36-42. Review.PMID: 11424975 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity